RESEARCH BY ATA®MEMBERS
To indicate the wide-ranging importance of thyroid research,
here is a sampling of ATA® members’ research accomplishments.
- Americans develop an estimated 250,000 thyroid nodules each year. Clinical research headed by ATA® members has led to cost-effective methods for screening thyroid nodules to detect malignancies. Other landmark studies by ATA® members have led to the development of powerful new tools for monitoring thyroid cancer patients.
- Research conducted decades ago by ATA® members led to mandatory screening of newborns for congenital hypothyroidism, and to early treatment that has prevented mental retardation in thousands. Today, pediatric research seeks to explain the connections between maternal and infant thyroid conditions and their long-term effects on babies’ cognitive development.
- ATA® research grants supporting groundbreaking work in brain development and thyroid hormone function have helped investigators collect the initial data required for successful grant applications to the National Institutes of Health.
- With ATA® support, a promising Graves’ disease genetic research study of 100 families may lead to improved prognosis and preventive treatments. Graves’ disease is an autoimmune disorder that runs in families and is thought to affect 1% of the population.
- A decade of research devoted to Graves’ ophthalmopathy has yielded greater understanding of the cellular processes involved in this debilitating eye disease, and led to the study of an experimental drug that may prove useful for treatment and prevention.
- Pioneering ATA® members’ work explained the thyroid-pituitary feedback mechanism. A cutting-edge new study focuses on how thyrotropin-releasing
hormone interacts with its receptor to regulate cellular function in the eyes, heart, pancreas, and central nervous system.
- ATA® members are using their scientific expertise and public health research findings to work for the global elimination of iodine deficiency and to study the effects of external head and neck radiation and nuclear fallout on the thyroid gland.
- ATA® has partnered with the Medullary Thyroid Carcinoma (MTC) Registry Consortium*to create a registry (list) of all new cases of MTC diagnosed in the United States over the next 10-15 years (the MTC Registry). The purpose of the MTC Registry is to help better understand what risk factors are associated with the development of MTC. Learn more…
How You Can Help
Thank you for your consideration of this important gift to thyroid research. With your help, there is new hope for the millions of people who suffer from thyroid disease.
Making a donation through our secure server is fast and easy, and when we receive your donation, we will send you an acknowledgement in the mail for tax purposes.
Up-to-date information for thyroid patients and their families is just a click away through our patient resource pages.
OTHER WAYS TO CONTRIBUTE
Vehicle Donation Program Unwanted vehicle? Don’t Trade In! Donate to us. Have an old car, truck, boat or other vehicle to donate? Click here to donate your vehicle online. Please note that this is a free service provided by V-DAC (Vehicle Donation to any Charity) and the service and pick-up is totally free. Any proceeds will go directly to support the American Thyroid Association
AmazonSmile Support the ATA® when you Shop Amazon. Amazon will donate .05% of the price of eligible purchases to our cause when selected. Register today with AmazonSmile smile.amazon.com
THANKS FOR YOUR SUPPORT!
Your Donations go to support the mission of the ATA® – education, research, patient care, scientific discovery
The American Thyroid Association® (ATA) is a 501 c3 nonprofit organization. Your gift is deductible according to tax law. The ATA Federal ID number is 41-6038600. The ATA® provides this information for the benefit of potential donors. It is not intended as legal or other professional advice. Individuals should always consult their own professional financial and legal counselors for such advice and decision-making.
American Thyroid Association
phone: 703 998-8890